LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/People In The News/Constance Chu, M.D. Wins Kappa Delta Award for MRI to Prevent OA
People In The News

Constance Chu, M.D. Wins Kappa Delta Award for MRI to Prevent OA

April 16, 2019 2 min read Premium comments

Advertisement

Constance Chu, M.D. Wins Kappa Delta Award for MRI to Prevent OA
Constance R. Chu, M.D.
#osteoarthritis#anteriorcruciateligament#constancechu

Constance R. Chu, M.D., professor and vice chair of research in the Department of Orthopedic Surgery at Stanford University, was recently presented with the Kappa Delta Elizabeth Winston Lanier Award at the 2019 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) for her research in advanced imaging technology to help prevent osteoarthritis (OA). Dr. Chu received the Kappa Delta Young Investigator Award in 2007.

Dr. Chu, director of the Joint Preservation Center and chief of Sports Medicine at the VA Palo Alto Health Care System, also discovered that many people with anterior cruciate ligament (ACL) injuries may have “pre-osteoarthritis” (pre-OA). Pre-OA, says Dr. Chu, means that the joint changes that occur before the onset of OA are potentially reversible.

Dr. Chu’s National Institutes of Health-funded research, which spanned nearly two decades, examined four imaging techniques to identify cartilage and joint abnormalities following joint injury. One of the techniques was a noninvasive procedure known as MRI UTE-T2* (Magnetic Resonance Imaging, Ultrashort Echo Time) mapping that produced color maps that showed variations in the deep layers of cartilage that are undetected by a regular MRI.

“If we can identify cartilage abnormalities before the surface breaks down, the patient can potentially recover with therapeutic interventions such as stem cells, gene therapy and improved walking mechanics,” said Dr. Chu. “…The MRI UTE-T2* imaging allows us to see changes beneath a seemingly healthy cartilage surface.”

Dr. Chu graduated from the U.S. Military Academy at West Point and earned her medical degree from Harvard Medical School. After attending West Point, Dr. Chu was a Military Intelligence Officer where she commanded an imaging intelligence unit, which led to her interest in imaging related to orthopedics.

Dr. Chu told OTW, “I am humbled by the honor and the long list of distinguished past recipients which confer the gravitas with which the orthopedic community views this award.”

“This honor conveys to me that research was judged to be of the highest quality and that orthopedic surgeons see great promise that our studies will help improve how they practice and care for patients in the near future. My team and I would like to make good on everyone’s faith in our work.”

“This is also the 70th year that the Kappa Delta sorority has sponsored this seminal award in orthopedics. I was thrilled to learn that a Kappa Delta sorority sister about to begin an orthopedic surgery residency was in the audience. I would love to know more about Elizabeth Winston Lanier and how the Kappa Delta sorority decided to establish the first award ever to honor orthopedic research.”

“Pre-OA is not OA. Rather, it is defined by potentially reversible markers of OA risk. To borrow an oft used phrase…you may not have seen it, but it has seen you. MRI UTE-T2* can help you and your patients see that their cartilage may be bruised or stressed in time for restorative treatment to promote healing so that progression to OA does not occur.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy